provisions which allows non-indexed articles entry into PMC, in case where (i) publishing journal is in the PMC journal list or where author has paid an open-access fee to a participating publisher program, either case, in which the publisher can deposit the file to PMC, or (ii) the paper is supported by an NIH grant and is deposited through NIH Manuscript Submission system, provided the journal is in NIH Public Access Policy Journal List. 3 Similarly, PubMed also has articles and journals submitted by the publisherwhich may never be indexed, but still do appear. To find them using Ovid, one of the Ovid MEDLINE databases include in-process and publisher-provided titles: "Ovid MEDLINE (R) In-Process and Other Non-Indexed Citations" and "Ovid MEDLINE (R) 1948 to Present." 4 To sum up, indexing in a database (ISI, MEDLINE, PubMed, SCOPUS, etc.) never reflects quality. Quality of each journal depends on the quality of each of its papers and its critical appraisal. Another basic fault remains that most researchers do not utilize the advanced search engine of PubMed, and resort to a more "Google style" database searching, which often leads to unrelated filtered results. Moreover, searching PubMed using only MeSH terms can most likely skip MEDLINE in-process and other non-indexed citations files. This exemplifies why we should search PubMed with words, phrases, and MeSH to get all available citations. Understanding MeSH's hierarchical arrangement is crucial to successful searching and sometimes the addition of a subheading results in a better representation of search subject.
Atypical generalized morphea-like scleroderma occurring in a patient exposed to organic solvents and having chronic hepatitis C virus infection
Sir, Generalized morphea-like scleroderma has been proposed as a subtype of diffuse cutaneous systemic sclerosis among people exposed to organic solvents. 1 Chronic hepatitis C virus (HCV) infection has been associated with many dermatologic conditions, including systemic sclerosis and localized scleroderma (morphea). 2, 3 We did not find any previous reports of generalized morphea-like scleroderma associated with HCV infection. Here, we describe an interesting case of atypical generalized morphea-like scleroderma occurring in a patient having chronic HCV infection and occupational exposure to organic solvents.
A 45-year-old male was referred to our department of dermatology for management of sclerotic plaques on the face and trunk. He had a history of occupational exposure to organic solvents (aliphatic hydrocarbons) for 7 years. He did not have any relevant history or predisposing factors for autoimmune diseases. One year earlier, he had noticed "tightness" of the skin on face, neck and back that got progressively worse. The patient complained of photosensitivity and dysphagia to solids. General physical examination was normal. Cutaneous examination showed sclerotic, hyperpigmented, plaques of 3-5 cms diameter [ Figure 1 ]. The lesions were distributed on the back, abdomen, neck, axillary folds, thigh and penis, and were associated with sclerosis of the upper face along with lower eyelid ectropion [ Figure 2 ]. The patient did not have sclerodactyly. Systemic examination was normal.
Laboratory tests including blood cell count, C-reactive protein, renal function tests and hepatobiliary enzyme levels were normal. Protein electrophoresis showed polyclonal hypergammaglobulinemia (chronic inflammatory disease profile). Antinuclear antibodies (ANA) (1/3200) and anti-centromere antibodies were positive (1/300). Anti-ds DNA and anti-scl70 antibodies were negative. Serology test for hepatitis B virus was negative, but it was positive for hepatitis C virus with a very high HCV viral load (1,330,000 IU/ml). Capillaroscopy showed minor capillary dystrophies without specific signs of microangiopathy. Skin biopsy showed hyperkertosis with orthokeratosis. The dermis was thickened and eccrine glands were abnormally situated within the upper dermis. Collagen fibers were broadened [ Figure 3 ]. A mild inflammatory cell infiltrate was present in the superficial dermis. Pulmonary function test showed a restrictive ventilatory deficit not associated with an abnormality of the alveolocapillary distribution, which was in favor of parietal origin of the restriction. Esophageal manometry showed a major hypotonia of the lower esophageal sphincter associated with retained overlying traction. Accordingly, the patient was diagnosed with generalized morphea-like scleroderma.
Generalized morphea-like scleroderma has features that include male predominance, rapid progression, high incidence of exposure to organic solvents and low incidence of internal organ involvement compared with the usual diffuse systemic sclerosis or scleroderma. 4 All these criteria were present in the case described here. Clinical features include symmetrical skin sclerosis demarcated from the surrounding areas, with an erythematous border and involving the upper lateral forearms, lumbar area and back. 4 Compared with generalized morphea-like scleroderma, sclerodactyly and visceral involvement are not observed in the usual generalized morphea patients. 5 The case described here is atypical due to the localization of the sclerosis on the upper face associated with lower eyelid ectropion and the absence of sclerodactyly. Previous authors have reported an association between organic solvent exposure and increased risk of systemic sclerosis. A meta-analytic review estimated the risk for occupational exposure to organic solvent being 2.4 (95% CI 1.7-3.4) in systemic sclerosis. 6 The pathogenic mechanisms of organic solvents in the onset of systemic sclerosis remains unclear. It has been suggested that organic solvents may link with nucleic acids and proteins, resulting in immune disruptors and increased risk of systemic sclerosis. 6 Generalized morphea-like scleroderma was first proposed as a unique subtype of diffuse systemic sclerosis in people exposed to organic solvents. 1 The development of a sclerodermatous condition has been suggested to be associated with exposure to various environmental agents, drugs (anti-cancer agents), irradiation and professional exposure to solvents, as in the case described here. These agents might damage endothelial cells and activate T cells with secretion of cytokines and chemokines, modulating the production of extracellular matrix proteins by fibroblasts. Chronic HCV infection has been associated with lichen planus, porphyria cutanea tarda, cutaneous necrotizing vasculitis, erythema nodosum and multiforme, urticaria, morphea and systemic sclerosis. 2, 3 In studies reporting the association of viral hepatitis and systemic sclerosis, the role of interferon therapy has been discussed. 2 Only a few cases of a sclerodermatous condition associated with HCV infection have been published. 2, 3 As the case presented here is atypical from the classical generalized morphea-like scleroderma associated with exposure to solvents, we suggest that HCV possibly caused the condition. To our knowledge, generalized morphea-like scleroderma associated with HCV infection has not been reported in literature.
The role of HCV infection in the pathogenesis of sclerodermatous condition is unknown. It is possible that the replication of HCV outside the liver, particularly in mononuclear cells, may suppress immune tolerance in genetically predisposed individuals. 2 Extrahepatic effects could be caused by circulating immune complexes depositing in tissues, viral antigens inducing autoantibodies reacting with local tissue antigens or the virus reacting directly on local tissue. 2, 3 Generalized morphea-like scleroderma described here is a rare entity associated with exposure to organic solvents, and its association with HCV infection has not been reported before.
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Eosinophilic fasciitis associated with Raynaud's phenomenon, esophageal dysmotility, positive antinuclear antibody and anti-neutrophil cytoplasmic antibody
Sir, A 33-year-old female agricultural laborer of Tamil origin presented with diffuse painful swelling of both forearms and legs of 5 months duration. She had difficulty in full extension of the fingers, getting up from sitting position, and raising hands above the shoulder. There was a history of Raynaud's phenomenon and burning retrosternal pain. She gave a history of strenuous manual work before the onset of the disease. Clinical examination revealed diffuse pitting edema bilaterally over forearms, hands, and legs, along with tightening of the skin and finger contractures. There was thickening and induration of the skin without any peau d' orange appearance. The overlying skin was shiny, and "groove sign" was visible on bilateral forearms and legs which got accentuated on raising the limbs [ Figure 1a and b]. A positive Raynaud's phenomenon was demonstrated by cold stimulation test. There were no fingertip ulcers, telangiectasia, or any evidence of pigmentary change. General and systemic examinations were within normal limit without any muscle tenderness or evidence of synovitis, and with normal chest expansion and breath sounds. A differential diagnosis of eosinophilic fasciitis and systemic sclerosis was considered. Nail fold capillaroscopy was within normal limit. Patient's total leukocyte count was 13500 per mm 3 (34% eosinophil), and erythrocyte sedimentation was 50 mm at the 1 st hour. Tested by immunofluorescence method, antinuclear antibody (ANA) was positive (4+ with centromere pattern). Cytoplasmic-anti-neutrophil cytoplasmic antibody (c-ANCA) was also positive. Esophageal scintigraphy demonstrated dysmotility in the lower third of the esophagus. Other investigations were within normal limits. A full thickness wedge skin biopsy revealed edema and thickening of subcutis and adjacent fascia along with moderate infiltration by lymphocytes, histiocytes, plasma cells, and eosinophil, which was consistent with the diagnosis of eosinophilic fasciitis [Figures 2 and 3 ]. The patient was put on 0.5 mg/kg prednisolone orally once daily. Due to poor response, oral methotrexate 15 mg weekly was added after 4 weeks. She 
